Gene Predictions

University of Auckland researchers have developed the world’s first test to measure the risk for individual smokers and ex-smokers of developing lung cancer with a simple mouth swab, trade named Respiragene. The test combines results of DNA analysis with other risk factors such as age, diseases such as bronchitis and emphysema and family lung cancer history, said University of Auckland associate professor Robert Young. “All smokers face an increased risk of developing lung cancer, among a host of other serious health problems, but for some individuals the risk is much greater than for others,” Young said. “With this test, doctors will be able to identify those at greatest risk while there is still time to help.” The test, developed by a company spun off from the University of Auckland called Synergenz Bioscience, is expected to be available worldwide before the end of the year.


Tags: DNA  lung cancer  Medical Health  Respiragene  Robert Young (Prof)  Synergenz Bioscience  Times of India  University of Auckland  

Emilia Wickstead Helping Airline Make an Impression

Emilia Wickstead Helping Airline Make an Impression

Around the globe, airlines and hotels are collaborating with top fashion houses to reshape brand narratives, like Air New Zealand and their partnership with London-based Emilia Wickstead. Condé Nast Traveler’s Caitlin…